ERBB2 and breast carcinoma: Search for “ERBB2” in this table shows that this gene, well known for its indications for treatment and prognosis in breast cancer,46-48 is included in 10 FDA-approved biomarker products—nine individual amplification markers and one panel, the Prosigna multigene prediction panel.